Share this page

Latest news

Article

Distribution of 30 million SMC drugs underway in the Sahel

26 August 2016
Latest News Access smc 2016 update from the field

As part of the 2016 ACCESS-SMC campaign, more than 30 million SMC treatments will be distributed to over six million children, living in seven countries[1] across the Sahel region. Distributions have now begun in almost all of the ACCESS-SMC supported countries, and will continue until November. Guinea has completed its second cycle of distribution and has achieved 99% coverage. Burkina Faso, the largest ACCESS-SMC programme with 8.2 million treatments to administer, has also completed its first cycle, with a coverage rate of 89% and is now rolling out the second cycle. Chad, Mali and Nigeria are running the first cycle distribution.   

 Number of children targeted by the 2015 and 2016 ACCESS-SMC distributions

Country

Number of targeted children, 2015

Number of targeted children, 2016

Burkina Faso

649,694

 

1,869,244

 

Chad

275,000

516,088

Guinea

210,107

378,570

Mali

809,638

1,287,907

 

Niger

595,901

955,394

Nigeria

792,133

1,735,602

The Gambia

90,925

75,378

One of the key successes of the first year of the ACCESS-SMC project is the diversification of the SMC market. As a result of this success, this year 65% of children will receive the new child-friendly dispersible formulation of the SMC preventive treatment. This dispersible formula is both easier to administer and is more palatable for the children. During a recent field trip to Mali, ACCESS-SMC Project Director, Diego Moroso witnessed the distribution of the dispersible formula:

“With the dispersible formulation, the children are more relaxed. They like the taste of the medicine and do not spit it out like last year. The new formulation is also much easier for the Community Health Workers to administer, as they no longer have to crush the drugs, add water and sugar before giving to the children, so it is less time consuming.”

At a WARN meeting held in July, WAHO stated that SMC is a valuable intervention for malaria control in children under 5 and that no significant resistance to SMC drugs is anticipated before 5 to 10 years. As a result, governments of SMC eligible countries are encouraged to rapidly scale up SMC interventions.

Take a look at the year one SMC campaign with this photo slideshow. 

[1] Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria, The Gambia

Related projects

ACCESS-SMC  

 

 

Click here for news archive »